Clinical Trial Update: ACURATE Enhance Post Market Study

View source ↗

Summary

The post-market study ACURATE Enhance (NCT06959862) sponsored by Boston Scientific has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Calcification
• Aortic Valve Disease
• Aortic Valve Stenosis

Drugs mentioned

• ACURATE Enhance

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Aortic Valve Stenosis, Aortic Valve Calcification | Status: WITHDRAWN